HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An unusual thrombolytic therapy decision in prosthetic valve thrombosis during early pregnancy.

Abstract
Pregnancy is among the risk factors for mechanical valve thrombosis, and even though thrombolytic therapy is contraindicated during pregnancy, it may be used in the treatment of this life-threatening complication. This case report describes a pregnant patient, whose echocardiogram showed evident gradient increase on her mechanical prosthetic mitral valve, and who was treated successfully with tissue plasminogen activator for mechanical valve thrombosis.
AuthorsErkan Köklü, İsa Öner Yüksel, Zehra Erkal, Selçuk Küçükseymen, Şakir Arslan
JournalTurk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir (Turk Kardiyol Dern Ars) Vol. 43 Issue 6 Pg. 554-7 (Sep 2015) ISSN: 1016-5169 [Print] Turkey
PMID26363749 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Diagnosis, Differential
  • Dyspnea (etiology)
  • Echocardiography, Transesophageal
  • Female
  • Heart Valve Prosthesis
  • Humans
  • Mitral Valve (diagnostic imaging, pathology)
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (diagnosis, diagnostic imaging, drug therapy)
  • Prenatal Diagnosis
  • Thrombolytic Therapy
  • Thrombosis (complications, diagnosis, diagnostic imaging, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: